Skip to main content

Sebastian Payne

Partner | Risk Advisory

As a Partner at Deloitte, I lead a team of Life Sciences specialists and specialize in Life Sciences Risk Advisory, bringing over 20 years of experience in LSHC consultancy. I assist organizations in navigating significant regulatory and technological changes in the Life Sciences sector, providing insights and strategic guidance.

Since June 2014, I have led Deloitte’s Business Services collaboration with the European Medicines Agency, overseeing several Deloitte-supported projects at the Agency. From 2016 to 2020, I served as the leader of Deloitte CORE (Centre of Regulatory Excellence for Life Sciences), a global initiative aimed at helping Life Sciences companies implement systems and processes to comply with current and emerging regulations. My current focus areas include GxP, Pharmacovigilance, ISO-IDMP, and the new Clinical Trials Regulation.

Market: Deloitte Netherlands

Let's connect

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities (collectively, the “Deloitte organization”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more. 

In The Netherlands the services are provided by independent subsidiaries or affiliates of Deloitte Holding B.V., an entity which is registered with the trade register in The Netherlands under number 40346342.

© 2024. For information, contact Deloitte Global.